Drug Side Effects
Search
BENZALKONIUM
BENZALKONIUM
was reported 439 times
BENZALKONIUM is most commonly taken among patients reporting these side effects:
#
Side effect
Count
Frequency
0
DERMABRASION
1
0.0238
1
GASTROINTESTINAL TOXICITY
20
0.0042
2
OCULAR SURFACE DISEASE
1
0.0036
3
MORGANELLA INFECTION
1
0.0034
4
INCORRECT PRODUCT FORMULATION ADMINISTERED
3
0.0034
5
C-REACTIVE PROTEIN ABNORMAL
20
0.0031
6
RHYTHM IDIOVENTRICULAR
1
0.0031
7
NEPHROSTOMY
1
0.0030
8
PULMONARY TOXICITY
20
0.0028
9
ABSCESS BACTERIAL
1
0.0028
10
TOXIC ANTERIOR SEGMENT SYNDROME
3
0.0027
11
LEUKOCYTURIA
1
0.0012
12
JOINT INJURY
20
0.0009
13
HEPATOTOXICITY
20
0.0009
14
JOINT STIFFNESS
20
0.0008
15
ACROCHORDON
1
0.0008
16
CULTURE URINE POSITIVE
1
0.0007
17
NODAL RHYTHM
1
0.0007
18
HEAT STROKE
1
0.0007
19
SINUS ARREST
1
0.0006
20
STAPHYLOCOCCUS TEST POSITIVE
1
0.0005
21
CATHETER SITE ERYTHEMA
1
0.0005
22
THERAPY NON-RESPONDER
20
0.0004
23
FLAT AFFECT
1
0.0004
24
MUSCULOSKELETAL PAIN
21
0.0004
25
CONTRAINDICATED PRODUCT ADMINISTERED
11
0.0004
26
NEOPLASM MALIGNANT
20
0.0003
27
WOUND COMPLICATION
1
0.0003
28
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS
2
0.0003
29
TREATMENT FAILURE
20
0.0002
30
MUSCULOSKELETAL STIFFNESS
20
0.0002
31
THERAPEUTIC PRODUCT EFFECT DECREASED
10
0.0002
32
ARTHROPATHY
12
0.0002
33
KLEBSIELLA INFECTION
1
0.0002
34
INFLAMMATION
10
0.0002
35
PRODUCT LEAKAGE
1
0.0002
36
SKIN WARM
1
0.0002
37
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
12
0.0002
38
JOINT SWELLING
20
0.0002
39
APHASIA
5
0.0002
40
ONYCHOCLASIS
1
0.0001
41
INFECTION
21
0.0001
42
RHEUMATOID ARTHRITIS
16
0.0001
43
RASH PUSTULAR
1
0.0001
44
SENSITIVE SKIN
1
0.0001
45
DRUG INTOLERANCE
12
0.0001
46
PETECHIAE
1
0.0001
47
SKIN INFECTION
1
0.0001
48
IMPAIRED DRIVING ABILITY
1
0.0001
49
DERMATITIS CONTACT
1
0.0001
50
COVID-19 PNEUMONIA
1
0.0001
51
NOCTURIA
1
0.0001
52
PAIN IN EXTREMITY
21
0.0001
53
DEVICE RELATED INFECTION
1
0.0001
54
PERIPHERAL SWELLING
10
0.0001
55
OBESITY
1
0.0001
56
CONDITION AGGRAVATED
19
0.0001
57
STAPHYLOCOCCAL INFECTION
2
0.0001
58
DRUG ERUPTION
1
0.0001
59
GLAUCOMA
1
0.0001
60
ARTHRALGIA
21
0.0001
61
UNRESPONSIVE TO STIMULI
1
0.0000
62
SKIN ULCER
1
0.0000
63
EXPOSURE VIA SKIN CONTACT
1
0.0000
64
FREQUENT BOWEL MOVEMENTS
1
0.0000
65
PALLOR
1
0.0000
66
SKIN LESION
1
0.0000
67
INJECTION SITE RASH
1
0.0000
68
DEVICE USE ERROR
1
0.0000
69
RASH MACULAR
1
0.0000
70
ELECTROCARDIOGRAM QT PROLONGED
1
0.0000
71
SEPSIS
3
0.0000
72
SKIN IRRITATION
1
0.0000
73
RASH ERYTHEMATOUS
1
0.0000
74
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES
1
0.0000
75
ECZEMA
1
0.0000
76
BRADYCARDIA
1
0.0000
77
RASH PRURITIC
1
0.0000
78
BLISTER
1
0.0000
79
EYE PAIN
1
0.0000
80
FLATULENCE
1
0.0000
81
DRUG INEFFECTIVE
21
0.0000
82
FEBRILE NEUTROPENIA
1
0.0000
83
INJECTION SITE PRURITUS
1
0.0000
84
BURNING SENSATION
1
0.0000
85
SKIN EXFOLIATION
1
0.0000
86
BALANCE DISORDER
1
0.0000
87
RASH
5
0.0000
88
DEVICE ISSUE
1
0.0000
89
HYPERSENSITIVITY
2
0.0000
90
SYNCOPE
1
0.0000
91
MALIGNANT NEOPLASM PROGRESSION
1
0.0000
92
MUSCULAR WEAKNESS
1
0.0000
93
OEDEMA PERIPHERAL
1
0.0000
94
INJECTION SITE ERYTHEMA
1
0.0000
95
OFF LABEL USE
7
0.0000
96
DRY SKIN
1
0.0000
97
VISION BLURRED
1
0.0000
98
PNEUMONIA
2
0.0000
99
CHEST PAIN
1
0.0000
100
BLOOD GLUCOSE INCREASED
1
0.0000
101
ERYTHEMA
1
0.0000
102
DEPRESSION
1
0.0000
103
ABDOMINAL PAIN
1
0.0000
104
DYSPNOEA
2
0.0000
105
PRODUCT DOSE OMISSION ISSUE
1
0.0000
106
INJECTION SITE PAIN
1
0.0000
107
PYREXIA
1
0.0000
108
ASTHENIA
1
0.0000
109
PAIN
1
0.0000
110
FATIGUE
1
0.0000
111
DEATH
1
0.0000